Odyssey Health, Inc. ODYY
Set alert
0.01 USD 0.00 -1.23%
As of Nov 2, 3:44 PM ET
0.008 Day range 0.0081
0.004 52-week range 0.08
- YTD
- -75.76%
- 1 year
- -89.19%
- Open
- 0.0081
- Prev close
- 0.0081
- Mkt cap
- 881.75K
- Vol
- 80.00K
- Avg vol
- 157.82K
- EPS
- -0.05
- P/E
- 0.00
More statistics
- Low
- 0.008
- High
- 0.0081
2Y chart
Signals (92)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 27, 2026 | 6 days ago |
| SMA: Bullish | Oct 23, 2026 | 1 week ago |
| MACD: Buy Signal | Oct 22, 2026 | 1 week ago |
| SMA: Bearish | Sep 29, 2026 | 1 month ago |
| SMA: Bullish | Sep 23, 2026 | 1 month ago |
| SMA: Bearish | Sep 22, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 22, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 16, 2026 | 1 month ago |
| RSI: Overbought | Sep 16, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 9, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 2, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 27, 2026 | 2 months ago |
| SMA: Bullish | Aug 4, 2026 | 3 months ago |
| MACD: Buy Signal | Jun 4, 2026 | 5 months ago |
| RSI: Oversold | May 12, 2026 | 5 months ago |
| SMA: Bearish | May 8, 2026 | 5 months ago |
| SMA: Bearish | May 6, 2026 | 6 months ago |
| SMA: Bullish | May 4, 2026 | 6 months ago |
| SMA: Bearish | Apr 30, 2026 | 6 months ago |
| SMA: Bullish | Apr 27, 2026 | 6 months ago |
Newest 20 of 92.
News
- Odyssey Health, Inc. (OTCMKTS:ODYY) Sees Significant Decline in Short Interest
- Head-To-Head Review: Odyssey Health (OTCMKTS:ODYY) & Enovis (NYSE:ENOV)
- Odyssey Health, Inc. Secures Exclusive Global Distribution Rights for BreastCheck™ to Drive Recurring Revenue Growth
- Odyssey Health, Inc. (OTCMKTS:ODYY) Short Interest Update
- Odyssey Health, Inc. Secures Multi-Million-Dollar, Nine-Year Service Contract and Financing Facility for Up to $25 Million
- Odyssey Health, Inc., Enters the $26 Billion Breast Cancer Marketplace
- Odyssey Health, Inc. to Advance Development of its Save A Life Choking Rescue Device
- Odyssey Health, Inc. Strengthens Balance Sheet with $8.7 Million in Net Equity
- Odyssey Health Closes Asset Sale of its Neurological Drug Technology Pipeline Including Concussion Drug Candidate with Oragenics, Inc.
- Odyssey Health, Inc. Gains Shareholder Approval for Asset Sale with Oragenics, Inc.
Your note
Sign in to keep a note on ODYY — it syncs with the Stock Master app.